Infinity Pharmaceuticals | INFI - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
AbbVie USD -6.66B 3.39B 2026-03
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Amgen USD 9.19B 532M 2026-03
AstraZeneca USD 47.33B 1.33B 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Cipla INR 344.32B 15.13B 2026-03
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 102.73M 58.9M 2025-12
CSL USD 18.66B 2.75B 2025-12
Eisai JPY 898.99B 9.36B 2026-03
Eli Lilly USD 31.2B 4.66B 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Grifols EUR 6.21B 133.12M 2025-12
Incyte USD 5.62B 455.37M 2026-03
Infinity Pharmaceuticals USD -37.41M 9.08M 2023-06
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
J&J USD 81.19B 358M 2026-03
Novartis USD 38.93B 7.2B 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Plus Therapeutics USD 11.96M 7.96M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
TG Therapeutics USD 583.13M 64.89M 2026-03